Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Escalier Biosciences brings in $19mm through Series B round

Executive Summary

Escalier Biosciences BV (RORyt (retinoic acid receptor-related orphan receptor gamma) compounds for dermatology and auto-immune conditions) closed a $19mm Series B round led by new backer Forbion (adds one of its partners to Escalier's board), which was joined by returning investors New Science Ventures and BioGeneration Ventures (BGV).
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies